← Every applicant
Be Pharms FDA Approvals
7 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| DALBAVANCIN HYDROCHLORIDENew drugJun 4, 2026POWDER, INTRAVENOUS |
| DEHYDRATED ALCOHOLNew drugOct 23, 2025SOLUTION, INTRAVENOUS |
| PHENYLEPHRINE HYDROCHLORIDENew drugJun 26, 2023SOLUTION, INTRAVENOUS |
| ENOXAPARIN SODIUM (PRESERVATIVE FREE)New drugJun 6, 2023INJECTABLE, SUBCUTANEOUS |
| PANTOPRAZOLE SODIUMNew drugMay 18, 2022INJECTABLE, INTRAVENOUS |
| SUCCINYLCHOLINE CHLORIDENew drugFeb 7, 2022INJECTABLE, INJECTION |
| SODIUM NITROPRUSSIDENew drugJul 12, 2021INJECTABLE, INJECTION |